| Summary: | 碩士 === 國立臺灣大學 === 商學研究所 === 98 === Many Teaching Hospitals participated in the General Clinical Research Center (GCRC) projects organized by the Department of Health. From the respects of these hospitals, there are15 required key components in clinical trial process in the hospital resources, which could be divided into two group, essential components and nonessential components. The study discusses the total management control of all clinical trial runs in the hospital. Two different business models are drawn according to different input levels. The two different models are most-input components operation model and least-input components operation model.
The differences between these two models are five components including center operation people (COP), IT, sample store (Sst), nurse (Nr), and laboratory (Lab). The study probes the impact of these five components on operation management, trials quality, and service quality, respectively. Finally, we discuss the difference in benefit, dominance, capacity, and revenue of these two operation models.
The least-input components operation model benefits from lower initial cost, but its extensibility is limited. While the effectiveness of clinical trial center is not clear in short-term with most-input components operation model, its advantages would reveal after reaching economies of scale. Furthermore, from the view of interest consistency, the study suggests that, first, teaching hospital should consider establish its core competence in clinical trials and cultivates two nonessential components, COP and Nr, and thus, we derived a more adequate model from those two models since the input level is between the two mentioned models.
The study suggests that the capacity of the clinical trial center of teaching hospital depends on the number of research nurses. If the hospital could undertake every trial with enough research nurses, clinical trial-qualified patients would be the dominant factor in its capacity, and hence, the promotion of the concept of clinical trials becomes more important. Finally, the competiveness of clinical trial centers would increase with good organization development, personnel cultivation, experience accumulation, and effectiveness promotion.
|
|---|
